- Home
- LIDR vs DXR Comparison
LIDR vs DXR Comparison
Compare LIDR & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIDR | DXR |
|---|---|---|
| Founded | 2013 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.5M | 59.0M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | LIDR | DXR |
|---|---|---|
| Price | $1.17 | $10.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $4.75 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 980.4K | 40.7K |
| Earning Date | 11-05-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $233,000.00 | ★ $1,446,345.00 |
| Revenue This Year | $952.79 | $44,489.33 |
| Revenue Next Year | $778.52 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ 15.35 | N/A |
| 52 Week Low | $1.01 | $8.56 |
| 52 Week High | $4.00 | $14.76 |
Technical Indicators
Market Signals| Indicator | LIDR | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 44.17 | N/A |
| Support Level | $1.16 | N/A |
| Resistance Level | $1.38 | N/A |
| Average True Range (ATR) | 0.04 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 25.00 | 0.00 |
Price Performance
Historical ComparisonAbout LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.